Rutgers scientists have found more clear-cut evidence of how the destructive proteins linked to Alzheimer's disease attack human brain cells and destroy surrounding tissue.
Jul 20, 2022
0
73
Advances in cellular immunotherapy that spur genetically modified T cells to attack cancer cells have revolutionized the treatment of certain blood cancers. Six such CAR-T cell therapies are approved by the Food and Drug ...
Jun 13, 2022
0
115
Non-small cell lung cancer (NSCLC) is a devastating disease and the leading cause of American cancer deaths. Even patients suitable for tumor removal have a 50% mortality rate. But University of Missouri School of Medicine ...
Apr 6, 2022
0
35
Infectious diseases kill millions of people each year, but the search for treatments is hampered by the fact that laboratory mice are not susceptible to some human viruses, including killers like human immunodeficiency virus ...
Nov 28, 2018
0
17
Scientists have designed a synthetic molecule that can reactivate dormant human immunodeficiency virus (HIV) in mice and lead to the death of some of the infected cells, according to a study published in PLOS Pathogens.
Sep 21, 2017
0
0
Scientists from the University of Granada (UGR) have patented an effective drug for treating cancer stem cells (CSCs) in breast, colon, and skin cancers. The researchers have proved the anti-tumor effects of the drug on immunodeficient ...
Oct 20, 2015
0
6
New UCLA research offers further evidence that cocaine use disrupts the immune system, making people who use it more likely to become infected with HIV.
Jun 18, 2015
0
36
Case Western Reserve University dental researcher Pushpa Pandiyan has discovered a new way to model how infection-fighting T cells cause inflammation in mice.
Feb 20, 2015
0
51
Imagine a type of personalized treatment where mice serve as surrogates to treat human disease.
May 20, 2014
0
0
One of the challenges to HIV vaccine development has been the lack of an animal model that accurately reflects the human immune response to the virus and how the virus evolves to evade that response. In the July 18 issue ...
Jul 18, 2012
0
0
